Related Experiment Videos
Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization
R Gastpar1, M Goldbrunner, D Marko
1Institut für Pharmazie, Universität Regensburg, D-93040 Regensburg, Germany.
Journal of Medicinal Chemistry
|December 4, 1998
Summary
Researchers identified key structural features of indolo[2, 1-a]isoquinoline compounds that inhibit tubulin polymerization, a crucial mechanism for cytostatic drugs. The most active derivative showed potent anticancer activity by disrupting microtubule assembly, similar to colchicine.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Cancer Research
Background:
- Tubulin polymerization inhibition is a primary mechanism for many cytostatic drugs.
- The 12-formyl-5,6-dihydroindolo[2, 1-a]isoquinoline scaffold is a promising structural class for developing new anticancer agents.
- Understanding structure-activity relationships is crucial for optimizing drug efficacy.
Purpose of the Study:
- To identify essential structural elements of the indolo[2, 1-a]isoquinoline system for tubulin polymerization inhibition.
- To synthesize and evaluate novel derivatives for cytostatic activity and tubulin polymerization inhibition.
- To elucidate the mechanism of action and binding mode of active compounds.
Main Methods:
- Synthesis of 2-phenylindole and indolo[2, 1-a]isoquinoline derivatives with varied oxygenation and nitrogen modifications.
- In vitro testing of cytostatic activity against human breast cancer cell lines (MDA-MB 231, MCF-7).
- Assay for tubulin polymerization inhibition and fluorescence microscopy for cytoskeleton analysis.
- Preliminary binding studies to determine the interaction site on tubulin.
Main Results:
- Derivative 3e (3-formyl-6-methoxy-2-(4-methoxyphenyl)indole) exhibited potent activity with IC50 values of 35 nM (cell growth) and 1.5 microM (tubulin polymerization).
- All potent cytostatic agents disrupted microtubule assembly, and derivative 3e mimicked colchicine's effect on the cytoskeleton.
- Methoxy derivatives were more potent in the 2-phenylindole series, while hydroxy derivatives were superior in the tetracyclic indolo[2, 1-a]isoquinoline series.
- Both compound classes bind to the colchicine site on tubulin.
Conclusions:
- Structural modifications of the indolo[2, 1-a]isoquinoline system can yield potent anticancer agents targeting tubulin polymerization.
- The position and type of oxygen substituents significantly influence activity, with distinct preferences in 2-phenylindole versus tetracyclic systems.
- These findings provide a basis for designing novel tubulin inhibitors with improved efficacy and specificity.